식품 병원균 검사 : 시장 점유율 분석, 업계 동향 및 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the food pathogen testing market size is expected to increase from USD 15.38 billion in 2025 to USD 16.54 billion in 2026 and reach USD 23.74 billion by 2031, growing at a CAGR of 8.04% over 2026-2031.

This report is Segmented by Type (Salmonella, E. Coli, Listeria, and Other Pathogens), Food Type (Meat and Poultry, Dairy Products, Fruits and Vegetables, and More), Technology (Polymerase Chain Reaction, Immunoassay-Based, Chromatography, and More), and Geography (North America, Europe, Asia-Pacific, South America, and the Middle East and Africa). Market Forecasts are Provided in Terms of Value (USD).

Global Food Pathogen Testing Market Trends and Insights

Escalating Foodborne Disease Burden Sustaining Persistent Testing Demand

WHO reported 866 million foodborne illness episodes each year and USD 310 billion in productivity losses in 2026, which gives food processors an economic reason to strengthen testing programs. Salmonella causes 200 million to 1 billion cases globally and an estimated 155,000 deaths each year, with 85.00% of cases linked to contaminated food. The FoodNet system recorded 24,624 laboratory-confirmed enteric infections across United States surveillance sites in 2024. Hospitalization rates remained elevated against the 2016-2018 reference baseline, which maintains pressure for more environmental monitoring and verification testing. Africa and South-East Asia account for nearly three-quarters of global foodborne illnesses, leaving a substantial need for testing capacity as laboratory infrastructure develops

Rapid Testing Technologies Reshaping Laboratory Workflows

The shift from culture-based methods to molecular detection is changing laboratory workflows in the Food pathogen testing market. Automated PCR workflows can provide sample-to-answer results in under 4 hours, while mid-range real-time PCR instruments are available below USD 40,000.00. These conditions allow regional contract laboratories to use molecular diagnostics with lower capital requirements than earlier platforms. Thermo Fisher Scientific launched InstaFlux in July 2026, and the system prepares enrichment media in under 30 minutes with gravimetric dispensing and digital audit trails that can connect with laboratory information systems. A 2026 review of 80 studies found that nanopore platforms can identify pathogens in under 24 hours with 95.00%-98.00% species-level accuracy, more than 90.00% antimicrobial-resistance gene sensitivity, and per-sample costs of USD 50.00-USD 200.00, compared with USD 300.00-USD 800.00 for conventional whole-genome sequencing.

High Capital and Operating Costs Limiting Adoption in Price-Sensitive Markets

High capital and operating costs limit adoption of advanced testing technologies in price-sensitive markets. Molecular platforms require instrument investment, reagent spending, maintenance contracts, specialist calibration, and bioinformatics support. A 2025 study found that whole-genome sequencing costs per sample exceed traditional typing methods during initial implementation. Cost parity occurs only when platforms are fully transitioned and used for several purposes, including serotyping and antimicrobial-resistance characterization. Lower investment reduces outbreak surveillance, which can weaken the documented basis for tighter regulations and slow laboratory development in South America and sub-Saharan Africa.

Other drivers and restraints analyzed in the detailed report include:

1. Preventive Food Safety Systems Driving Environmental Monitoring Volumes
2. Food Processing Sector Expansion in Emerging Markets Opening New Testing Volumes
3. Lack of Standardization Impeding Cross-Border Testing Recognition

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Salmonella held 43.28% of the Food pathogen testing market size by type in 2025. Its position reflects broad testing requirements across poultry, meat, and egg supply chains. The Food Safety and Inspection Service continued Salmonella verification testing across young chicken carcasses, comminuted poultry, and raw chicken parts through the April 2025-April 2026 cycle. This program maintains testing demand through slaughter, processing, and further-processing operations. The proposed Food Safety and Inspection Service framework for raw poultry included statistical process control monitoring requirements in early 2025. If finalized, this framework would raise testing frequency at individual establishments. Salmonella testing also remains central to outbreak investigation and supplier verification. These requirements support its leading revenue position in the Food pathogen testing market.

E. coli is forecast to record the highest type-level CAGR of 9.55% from 2026 to 2031. Testing demand comes from dairy, produce, and meat channels. The Food and Drug Administration's evolving pre-harvest agricultural water requirements under the Produce Safety Rule add to this demand. Listeria and other pathogens account for the remaining type revenue. A multistate Listeria outbreak linked to soft cheese in June 2026 caused 1 death and 7 hospitalizations. The event reinforced the case for continuous environmental Listeria monitoring in dairy facilities. Testing programs increasingly need to address distinct risks across raw materials, equipment surfaces, and finished products. This supports a broader pathogen panel beyond the largest target category.

Complete Report Scope:

• By Type
  • Salmonella
  • E-Coli
  • Listeria
  • Other Pathogens
• By Food Type
  • Food
    • Meat and Poultry
    • Dairy Products
    • Fruits and Vegetables
    • Processed Food
    • Crops
    • Other Foods (Spices, Infant Formula)
  • Pet Food and Animal Feed
• By Technology
  • Polymerase Chain Reaction
  • Immunoassay-based
  • Chromatography and Spectrometry
  • Others
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Netherlands
    • Sweden
    • Poland
    • Belgium
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Vietnam
    • Indonesia
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Chile
    • Peru
    • Colombia
    • Rest of South America
  • Middle East and Africa
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of Middle East and Africa

Geography Analysis

North America held 41.36% of the Food pathogen testing market share in 2025. The region's position is supported by Food Safety Modernization Act preventive controls and extensive Food Safety and Inspection Service verification programs. The United States accounts for most regional revenue, with active Salmonella verification testing across poultry and meat establishments through 2026. E. coli and Listeria events in dairy during 2026 are increasing environmental monitoring among affected producers. SGS acquired Murray-Brown Laboratories in March 2026, expanding its North American PCR and advanced microbial detection capabilities.

Europe is the second-largest regional area, led by Germany, the United Kingdom, France, Italy, and the Netherlands. Demand is supported by major food processing activity and harmonized microbiological criteria under Regulation (EC) 2073/2005. Commission Implementing Regulation (EU) 2025/179 requires whole-genome sequencing of outbreak isolates for 4 key pathogens from August 23, 2026. National Reference Laboratories must obtain ISO/IEC 17025:2017 accreditation for this work by mid-2028. Eurofins Agro Testing completed the acquisition of Laborator Postoloprty in the Czech Republic in June 2026. Brazil and Argentina drive South American demand through meat, soy, and aquaculture export certification. bioMerieux acquired Neoprospecta in Brazil in January 2025, strengthening its data and genomics offering in Latin America. Merieux NutriSciences also expanded its footprint through the acquisition of Bureau Veritas food testing activities.

Asia-Pacific is forecast to grow at a 9.57% CAGR from 2026 to 2031. China, India, Vietnam, and Indonesia are adopting molecular methods on new testing infrastructure rather than primarily replacing mature culture-based systems. China's GB/T 27405-2026 and GB/T 27403-2026 create national frameworks for laboratory quality control and molecular biological testing. India's FSSAI amendment takes effect in December 2026 and creates a concentrated procurement need for manufacturers, importers, and seafood processors. Middle East and Africa is the smallest regional area, but the United Arab Emirates and Saudi Arabia maintain institutional demand as major food importers. Africa's large foodborne disease burden points to a continuing gap between testing needs and available laboratory capacity. Laboratory investment and food-safety assistance could help narrow this gap over time.

1. Eurofins Scientific
2. SGS S.A.
3. Merieux NutriSciences
4. Intertek Group plc
5. Neogen Corporation
6. Thermo Fisher Scientific Inc.
7. Bio-Rad Laboratories, Inc.
8. bioMerieux S.A.
9. QIAGEN N.V.
10. 3M Company
11. ALS Limited
12. Bureau Veritas S.A.
13. TUV SUD AG
14. Charm Sciences, Inc.
15. Romer Labs
16. Hygiena LLC
17. Microbac Laboratories, Inc.
18. AsureQuality Limited
19. Tentamus Group GmbH
20. Certified Group
21. Element Materials Technology Group

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions and Market Definition
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Increasing Incidence of Foodborne Diseases
  • 4.2.2 Growing Demand for Food Safety and Quality
  • 4.2.3 Increasing Adoption of Rapid Testing Technologies
  • 4.2.4 Growing Emphasis on Preventive Food Safety Systems
  • 4.2.5 Expansion of Food Processing Industries in Emerging Markets
  • 4.2.6 Stringent Food Safety and Government Regulations on Pathogen Testing
• 4.3 Market Restraints
  • 4.3.1 High Cost of Advanced Testing Technologies
  • 4.3.2 Long Testing and Confirmation Procedures
  • 4.3.3 Lack of Standardization Across Countries
  • 4.3.4 Complexity of Food Matrices
• 4.4 Supply Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces
  • 4.7.1 Bargaining Power of Suppliers
  • 4.7.2 Bargaining Power of Buyers
  • 4.7.3 Threat of New Entrants
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Competitive Rivalry

5 MARKET SIZE AND GROWTH FORECASTS (VALUE)

• 5.1 By Type
  • 5.1.1 Salmonella
  • 5.1.2 E-Coli
  • 5.1.3 Listeria
  • 5.1.4 Other Pathogens
• 5.2 By Food Type
  • 5.2.1 Food
    • 5.2.1.1 Meat and Poultry
    • 5.2.1.2 Dairy Products
    • 5.2.1.3 Fruits and Vegetables
    • 5.2.1.4 Processed Food
    • 5.2.1.5 Crops
    • 5.2.1.6 Other Foods (Spices, Infant Formula)
  • 5.2.2 Pet Food and Animal Feed
• 5.3 By Technology
  • 5.3.1 Polymerase Chain Reaction
  • 5.3.2 Immunoassay-based
  • 5.3.3 Chromatography and Spectrometry
  • 5.3.4 Others
• 5.4 By Geography
  • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.1.4 Rest of North America
  • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Netherlands
    • 5.4.2.7 Sweden
    • 5.4.2.8 Poland
    • 5.4.2.9 Belgium
    • 5.4.2.10 Rest of Europe
  • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 India
    • 5.4.3.3 Japan
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Vietnam
    • 5.4.3.7 Indonesia
    • 5.4.3.8 Rest of Asia-Pacific
  • 5.4.4 South America
    • 5.4.4.1 Brazil
    • 5.4.4.2 Argentina
    • 5.4.4.3 Chile
    • 5.4.4.4 Peru
    • 5.4.4.5 Colombia
    • 5.4.4.6 Rest of South America
  • 5.4.5 Middle East and Africa
    • 5.4.5.1 United Arab Emirates
    • 5.4.5.2 Saudi Arabia
    • 5.4.5.3 South Africa
    • 5.4.5.4 Nigeria
    • 5.4.5.5 Rest of Middle East and Africa

6 COMPETITIVE LANDSCAPE

• 6.1 Market Concentration
• 6.2 Strategic Moves
• 6.3 Market Ranking Analysis
• 6.4 Company Profiles (Includes Global-level Overview, Market-level Overview, Core Segments, Financials, Strategic Info, Market Rank/Share, Products & Services, Recent Developments)
  • 6.4.1 Eurofins Scientific
  • 6.4.2 SGS S.A.
  • 6.4.3 Merieux NutriSciences
  • 6.4.4 Intertek Group plc
  • 6.4.5 Neogen Corporation
  • 6.4.6 Thermo Fisher Scientific Inc.
  • 6.4.7 Bio-Rad Laboratories, Inc.
  • 6.4.8 bioMerieux S.A.
  • 6.4.9 QIAGEN N.V.
  • 6.4.10 3M Company
  • 6.4.11 ALS Limited
  • 6.4.12 Bureau Veritas S.A.
  • 6.4.13 TUV SUD AG
  • 6.4.14 Charm Sciences, Inc.
  • 6.4.15 Romer Labs
  • 6.4.16 Hygiena LLC
  • 6.4.17 Microbac Laboratories, Inc.
  • 6.4.18 AsureQuality Limited
  • 6.4.19 Tentamus Group GmbH
  • 6.4.20 Certified Group
  • 6.4.21 Element Materials Technology Group

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK